OpenAI's GPT-Rosalind agents analyze millions of mouse brain cells in 32 minutes, accelerating neurodegenerative disease research
Distributed AI agents powered by GPT-Rosalind completed a month-long gene disruption analysis in half an hour, identifying new leads for Alzheimer's and Parkinson's treatments.